Literature DB >> 478592

Chemotactic factor inactivator release from rat leukocytes.

J D Hunt, P A Ward.   

Abstract

Rat neutrophils, alveolar macrophages, and peritoneal macrophages each released chemotactic factor inactivator (CFI) activities under conditions of endocytosis (uptake of opsonized zymosan particles and preformed immune complexes). CFI activities in supernatant fluids from phagocytizing leukocytes were found for the chemotactic factors from the third (C3) and the fifth (C5) components of complement and for the bacterial chemotactic factor (present in culture supernatant fluids from Escherichia coli.) CFI activity could also be demonstrated in homogenates obtained from disrupted leukocytes. CFI release from intact leukocytes was dependent on the duration of incubation of leukocytes with the phagocytic stimulus. No quantitative relationships were noted between the amount of CFI activity and the amount of beta-glucuronidase in phagocytic supernatant fluids released from leukocytes. The release of CFI activities from phagocytizing leukocytes may represent a regulatory ("turn-off") mechanism for the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478592     DOI: 10.1007/bf00914177

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

2.  Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.

Authors:  J A Kazmierowski; J I Gallin; H Y Reynolds
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

3.  Quantitative phagocytosis by neutrophils. I. A new method with immune complexes.

Authors:  P A Ward; N J Zvaifler
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

4.  Antileukotactic properties of tumor cells.

Authors:  J P Brozna; P A Ward
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

5.  Chemotactic factor inactivator in normal human serum.

Authors:  J L Berenberg; P A Ward
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

6.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

7.  Acute immunologic pulmonary alveolitis.

Authors:  K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

8.  Chemotoxis of mononuclear cells.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

9.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis.

Authors:  C G COCHRANE; W O WEIGLE; F J DIXON
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.